非二元性别患者初次代谢减重手术的患病率与短期结局:MBSAQIP数据库分析
基于MBSAQIP数据库2020-2023年回顾性分析692615例初次袖状胃切除和Roux-en-Y胃旁路术患者,其中272例(0.04%)为非二元性别。非二元患者较二元性别患者更年轻、BMI更高、阻塞性睡眠呼吸暂停比例更高,30天再入院率更高(6.3% vs 2.9%),但严重并发症无显著差异;非二元身份独立预测再入院(OR 2.19),非严重并发症独立预测因子(OR 0.98)。
要点
- 非二元性别患者占初次代谢减重手术的0.04%,研究期间数量翻倍以上。
- 非二元患者30天再入院率6.3% vs 二元患者2.9%,非二元身份独立预测再入院(OR 2.19)。
- 严重并发症、再手术、漏、出血、VTE无显著差异;非二元身份非严重并发症独立预测因子(OR 0.98)。
核心结论
- 非二元患者在接受初次代谢减重手术的人群中占比小但不断增加。
- 在该30天MBSAQIP分析中,非二元身份与再入院 odds 升高独立相关,但与严重并发症 adjusted odds 升高无关。
- 鉴于非二元队列样本量小且再入院详细信息有限,这些发现应谨慎解读,并支持需要更细致的性别数据收集和长期结局研究。
研究设计与样本
- 回顾性分析2020-2023年MBSAQIP数据库,纳入接受初次袖状胃切除(SG)和Roux-en-Y胃旁路术(RYGB)的成人患者,按性别身份分层。
- 比较基线人口学、合并症、手术细节和30天结局,并使用多因素logistic回归识别严重术后并发症的预测因素。
主要发现
- 共692615例患者,其中272例(0.04%)为非二元性别,其数量在研究期间翻倍以上。
- 非二元队列较二元队列更年轻(37.3 ± 11.1 vs 43.1 ± 11.8岁,p < 0.0001),BMI更高(46.7 ± 8.6 vs 45.1 ± 7.7 kg/m2,p = 0.001),阻塞性睡眠呼吸暂停比例更高(45.6% vs 37.2%,p = 0.004)。
- 非二元队列更多接受RYGB(32.7% vs 27.2%,p = 0.040),手术时间更长(91.2 ± 49.2 vs 84.4 ± 49.2 min,p = 0.004),30天再入院率更高(6.3% vs 2.9%,p = 0.001)。
- 再手术、漏、出血、VTE或严重并发症发生率无显著差异。
- 非二元身份不是严重并发症的独立预测因子(OR 0.98,95% CI 0.46-2.08,p = 0.958),但独立预测更高的30天再入院率(OR 2.19,95% CI 1.33-3.59;p = 0.002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 非二元队列样本量小。
- 再入院详细信息有限。
- 这些发现应谨慎解读。
- 支持需要更细致的性别数据收集和长期结局研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Non-binary individuals represent a growing demographic in the U.S. and experience higher rates of obesity. Metabolic and bariatric surgery (MBS) is the most effective treatment for patients with severe and complex obesity, yet data on its use and outcomes in non-binary patients have not yet been studied. Existing research has focused on binary gender categories, leaving a critical gap in understanding surgical outcomes for non-binary individuals. This study compared perioperative characteristics and 30-day outcomes of MBS between non-binary and binary patients. METHODS: A retrospective analysis of the 2020-2023 MBSAQIP database included adult patients undergoing primary sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), stratified by gender identity. Baseline demographics, comorbidities, operative details, and 30-day outcomes were compared. Multivariable logistic regression was used to identify predictors of serious postoperative complications. RESULTS: Among 692,615 patients, 272 (0.04%) identified as non-binary. Their numbers more than doubled over the study period. Compared to binary cohort, non-binary cohort were younger (37.3 ± 11.1 vs. 43.1 ± 11.8 years, p < 0.0001), had higher BMI (46.7 ± 8.6 vs. 45.1 ± 7.7 kg/m2, p = 0.001), and had higher proportions of obstructive sleep apnea (45.6% vs. 37.2%, p = 0.004). They underwent RYGB more often (32.7% vs. 27.2%, p = 0.040), had longer operative times (91.2 ± 49.2 vs. 84.4 ± 49.2 min, p = 0.004), and higher 30-day readmission rates (6.3% vs. 2.9%, p = 0.001). No significant differences were found in rates of reoperation, leak, bleeding, VTE, or serious complications. Non-binary identity was not an independent predictor of serious complications (OR 0.98, 95% CI 0.46-2.08, p = 0.958). In contrast, non-binary identity independently predicted higher 30-day readmission rates (OR 2.19, 95% CI 1.33-3.59; p = 0.002). CONCLUSIONS: Non-binary patients represented a small but increasing proportion of patients undergoing primary MBS. In this 30-day MBSAQIP analysis, non-binary status was independently associated with higher odds of readmission but was not associated with increased adjusted odds of serious complications. Given the small non-binary cohort and limited readmission-detail availability, these findings should be interpreted cautiously and support the need for more nuanced gender data collection and long-term outcomes research.
引用
- Kachornvitaya P, Wills M, Barajas-Gamboa J, et al. Prevalence and short-term outcomes of primary metabolic and bariatric surgery in non-binary patients: an analysis of the MBSAQIP database. Surg Endosc. 2026. PMID: 42552485. doi:10.1007/s00464-026-13145-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。